Category: Drug Law Reform

  • How Does NAFTA Impact Drug Policy?

    How Does NAFTA Impact Drug Policy?

    What does the North American Free Trade Agreement have to do with drug policy? At first glance they might seem like unrelated topics. But as the Caravan4Peace makes its way across the southern United States, we in Canada have a chance to pause and reflect on how our policies might be making the effects of the war on drugs on the U.S./Mexico border that much worse.

    Trade agreements like NAFTA are touted as the key to dynamic growth in nations like Mexico and Canada. But a policy brief from the Carnegie Endowment for International Peace suggests that agreements between trading partners don’t always realize such lofty goals, nor do they stand in for more multifaceted approaches to development.

    In fact, Mexico’s reforms backed by NAFTA have been disappointing at best. At worst, these ‘reforms’ have contributed to making Mexico ideal for drug production and trafficking. Though trade has certainly increased, economic growth has been slow and job creation weak. Limited employment gains in manufacturing and services have been offset by large employment losses in agriculture. Needed wage increases, especially for unskilled labourers, have not materialized. What this means is that rural areas, farmers and the poor have been the least likely to reap the benefits of liberalized trade policies. Rural poverty runs at 55% overall with 25% living in extreme poverty, and Mexico remains one of the hemisphere’s most unequal countries.

    So we have to ask, what does this continued impoverishment of the agriculture sector and small-scale farmers mean for drug control policies? Some small-scale farmers face tremendous challenges and live in conditions of poverty, social exclusion and government neglect. These conditions affect their decision to become involved in the illegal drug trade. In addition, lack of other economic opportunities, including fair wages and good quality employment, pushes poor people into the trade as small-time dealers and drug mules.

    I’m not suggesting that NAFTA can be held fully accountable for the current situation on the U.S./Mexico border where violence has been widely reported in the media. To some extent, this violence has been precipitated by increased drug-related police activities. Mexican president Felipe Calderón declared a “war on drugs” upon assuming office in December 2006. Since then, there has been an unprecedented rise in crime and violence in the country, with over 47,000 people violently killed in the past 5 years. In 2008, for example, half the homicides in Mexico were directly linked to the drug trade. Though it might seem counter-intuitive to some, a systematic review of research of the impacts of drug-related law enforcement on drug-market violence found that increased drug-related law enforcement was associated with increasing levels of drug-market violence. Though the violence is often attributed to inter-cartel conflict, the police and the military have played at least some role in perpetrating this violence.[1] At the same time, U.S. funding through the Merida initiative has increased equipment and training supplied to Mexico’s police forces and Mexico has been cited for its human rights violations.[2]

    What observers such as the Washington Office on Latin America have also noted is that the U.S.-led war on drugs has failed to suppress illicit drug production or trafficking, while harsh drug laws have led to human rights abuses, overcrowded prisons and threats to democratic institutions. Thousands of Mexicans have been killed, disappeared and displaced as a result of the drug war. But efforts to subject these drug control policies to scrutiny are hindered by claims that the drug trade is a threat to U.S. national security and trade relations.

    The recent Summit of the Areas in Cartagena revealed the extent to which Latin America is a rising global power. Several leaders in Central and South America challenged U.S. economic and security policies. And groups like the Latin American Commission on Drugs and Democracy are challenging U.S. dominated prohibitionist policies. The Commission’s reports demand that both the U.S. and Canada examine their complicity in the drug trade as key drug-consuming nations.

    Canada has recognized that the Americas are important partners in hemispheric relations. We designated Latin America as a foreign policy priority in 2007. But our record of action to-date has been narrowly focused on trade and securitization of the area. Securitization, including increased policing, border patrols, militarization of civil society, and suppression of dissent are central to the strategies of the war on drugs.

    A quick visit to the website for Foreign Affairs and International Trade will link readers to press releases about Canada’s aid to Latin America to support security measures. Canada, through its aid programs, is a full partner in prohibitionist global drug control programs. Again, I’m not suggesting that we abandon efforts to bolster public safety, but it worries me that Canada has chosen to narrow its focus to security and trade agreements at the expense of more multifaceted and socially just approaches that foster development and social inclusion. I’m not alone. The Americas Policy Working Group at the Canadian Council for International Cooperation (CCIC) has raised some of the same concerns.

    The CCIC invites Canadian policy makers to re-focus its policy priorities for nations like Mexico on a strategy that centres on human rights, broad-based participation in decision-making and development. Canadian approaches to aid and trade must address, not exacerbate, the root causes of drug and criminality problems in the Americas and recognize that militaristic approaches are detrimental to public safety.

    So next time you hear someone touting the benefits of free trade, ask yourself: will these policies bolster democratic institutions, socially just development strategies and evidence and rights-based drug policies?

  • Caravan for Peace with Dignity and Justice

    Caravan for Peace with Dignity and Justice

    footerBlog60,000 killed, 10,000 disappeared and 160,000 displaced.

    This is the ongoing tragedy that has been wrought upon the Mexican people in the few short years since Felipe Calderón declared a “war on cartels” in December, 2006.

    Javier Sicilia, the famed Mexican poet, stopped writing poetry after his son was gunned down in Cuernavaca in March, 2011. On the day his son died he wrote one final verse before putting down his pen: “the world is not worthy of words, they have been suffocated from the inside, just as they suffocated you.”

    caravan2
    CC photo by Caravan4Peace

    Since then he has been taking to the streets of Mexico, with hundreds of thousands of other citizens in a dramatic plea to the drug cartels and the government to stop the violence that has been tearing apart their country. Sicilia, as he is known in Mexico, led two Caravans for Peace – one from Cuernavaca to Mexico City and the other through the north of Mexico, where the violence has been beyond comprehension.

    On August 12th, Sicilia led close to a hundred victims of the drug war in Mexico across the border from Tijuana to San Diego to begin a month-long Caravan for Peace across the southern and north eastern US. The overarching message of the Caravan for Peace is that the war on drugs continues to devastate his country and is the result of drug policies initiated in the U.S., Canada and Mexico. CDPC will be joining the Caravan for Peace in Baltimore, Maryland on September 9th as it stops to hold a Town Hall Meeting on drug policy that will look at how all three countries have much to gain by considering alternatives to a failed war on drugs.

    Follow our blog in the coming weeks to read more about the Caravan for Peace, Javier Sicilia, and Canada’s relationship to Mexico’s drug war.

  • Drug policy off-limits at AIDS 2012 Opening

    Drug policy off-limits at AIDS 2012 Opening

    The opening session of AIDS 2012 is the anchor event for many attendees. This is the place where world leaders in the AIDS movement say their piece and inspire attendees to continue their work. Speakers at this year’s session were numerous and notable, including World Bank President Jim Yong Kim, who delivered the message that his organization cares and wants to see more involvement of civil society in shaping global anti-poverty programs (despite years of insisting that countries scale down their social safety nets to receive World Bank financial assistance). The conference co-chairs, Diane Havlir and Elly Katabira, along with the Deputy President of South Africa also urged conference attendees to embrace the goal of eliminating HIV in our generation. All good stuff.

    New Vienna Declaration Ad
    New Vienna Declaration Ad

    The highlight of the evening was Annah Sango from the International Community of Women Living with HIV/AIDS who spoke most poignantly about the need to integrate women’s issues into the international AIDS agenda. She praised the work of NGO’s addressing the needs of people who use drugs and reminded the audience that the way forward cannot proceed without the voices of those most affected, including people who use drugs, women, and sex workers. Speakers made it clear that organizations focused on AIDS in a global context have had major successes at scaling up prevention and treatment. Yet it was apparent that discussion of controversial issues like the decriminalization or even legalization of drugs was a nonstarter. Last night’s speakers briefly mentioned needle exchange but the overall framework of global drug policy was clearly not on the agenda.

    These profound absences were supposed to be remedied by the 2010 Vienna Declaration. But the lack of drug policy discussion last night makes it clear why CDPC’s presence is needed in Washington this week. Our work is to remind attendees that drug policy is AIDS policy and that harm reduction interventions and a discussion of legal frameworks should not only be up for discussion, but are central to the conference’s goal of an AIDS-free generation.

  • Drug Courts in Canada: the Good, the Bad and the Badly Researched

    Drug Courts in Canada: the Good, the Bad and the Badly Researched

    Drug treatment courts (DTC’s) are often touted as the solution to a cycle of drug addiction and crime. But are they? That’s the question the Canadian HIV/AIDS Legal Network sought to answer in a 2011 publication that reviews the operations of six federally funded drug courts in Canada (Toronto, Edmonton, Vancouver, Winnipeg, Ottawa and Regina). This study is also a detailed primer on drug courts for the uninitiated. The report does not completely dismiss DTC’s but raises some serious questions about how they operate and their effectiveness.

    Photo: Some rights reserved by s_falkow
    Photo: Some rights reserved by s_falkow

    The notion that addiction is the result of a moral failing sometimes gives way to the idea that it’s a chronic illness that will respond to medical treatment. But as this report points out, drug courts operate on a combination of these assumptions.

    Promoted as a way to reduce drug use and prevent crime, drug courts embrace the idea that treatment can alleviate addiction.

    But they also use quasi-coercive and punishing methods more akin to the criminal justice system. Applicants to a drug court treatment program must plead guilty to a crime and submit to a mandatory urine screening. Failure to adhere to the court ordered treatment program can mean a prison sentence. But if addiction is a chronic relapsing illness as the United Nations Office on Drugs and Crimes suggests it is, how well does it respond to these quasi-coercive  techniques used in drug courts? Not that well according to the authors of this report.

    This report also raises serious questions about the methodology of research on drug courts. Its authors argue that given the lack of follow-up research on the experiences of participants, and the low retention rates in many DTC programs, it’s difficult to conclude at this stage whether or not drug courts result in decreased drug use and/or recidivism. More alarmingly, these authors found that women are less likely to apply to DTC’s and less likely to graduate at comparable levels to men, partly due to a lack of gender specific programming and program flexibility that accommodates parenting responsibilities. Indigenous women and men are also less likely to complete drug court programs due in part to the lack of Indigenous-specific treatment services.

    Screen-shot-2012-07-18-at-7.46.53-AM-230x300
    Download the report

    The report’s authors question how voluntary the entry to treatment is when prison is the alternative and access to other treatments are limited. As stated in the report,

    “given the difficulty of obtaining drug treatment and social services without going through the DTC system, it is questionable whether a person is voluntarily entering DTC.”

    The authors also point out that a DTC system can potentially undermine some of the safeguards of the traditional judicial system. Drug courts may also violate human rights, specifically, the right to health outlined in Article 12 of the International Covenant on Civil and Political Rights because participants can be denied access to a health service if they do not follow the rules of a DTC program.

    Overall, this report questions whether dedicating limited resources to quasi-compulsory drug treatment via the criminal justice system, rather than scaling up access to quality voluntary treatment, is the best way to help people limit their drug use and prevent recidivism.

    For more information see: Impaired Judgment: Assessing the Appropriateness of Drug Treatment Courts as a Response to Drug Use in Canada from the Canadian HIV/AIDS Legal Network. Available at: http://www.aidslaw.ca/publications/publicationsdocEN.php?ref=1302

     

     

  • The Global Commission on the war on drugs and HIV/AIDS

    The Global Commission on the war on drugs and HIV/AIDS

    On June 26th, the Global Commission on Drug Policy released a groundbreaking report on the war on drugs and its failures. Titled “The war on drugs and HIV/AIDS: How the criminalization of drugs fuels the global pandemic”, the report focuses on the relationship between drug policy and the spread of HIV.

    Global Commission Report Launch with Michel Kazatchkine, Ruth Dreifuss and Ilona Szabó
    Global Commission Report Launch with Michel Kazatchkine, Ruth Dreifuss and Ilona Szabó

    Covering a range of issues directly connected to the HIV and AIDS pandemic, the report points out the inability of law enforcement to reduce global drug supply. In fact, the global supply of illicit opiates, such as heroin, has increased by 380% in recent decades. And it describes how repressive drug control policies actually drive the HIV epidemic in many regions of the world. The report also details how policies that prohibit needle exchange increase syringe sharing and the risk of HIV infections, and how the fear of arrest drives people underground and away from needed services. It urges countries to scale up proven drug treatment and public health measures, including harm reduction services, to reduce HIV infection and protect community health and safety.

    Canada often prides itself on being a positive and progressive force on the international stage. But politics, rather than evidence, tend to be the deciding factor in defining Canadian drug policy. As the Global Commission’s report explains, mass incarceration also drives the HIV pandemic. The recent passage of the Omnibus Crime Legislation prescribes mandatory minimum penalties for some drug crimes. This will have the effect of driving up incarceration rates in Canada’s already crowded prisons, and as the Canadian HIV/AIDs Legal Network recently pointed out, the lack of needle exchange programs in Canadian prisons contributes to the spread of HIV and endangers public health.

    The report also documents how the fight against HIV is being won in countries where problematic substance use is treated as a health issue. In Australia and European countries such as Portugal and Switzerland, newly diagnosed HIV infections have been nearly eliminated among people who use drugs.

    The Global Commission members are no lightweights when it comes the development of governmental policy. The Commission comprises a distinguished group of high-level leaders whose ranks include George Schultz, former US Secretary of State, Richard Branson, founder of the Virgin Group and advocate for social causes, and Ruth Dreifuss, former President of Switzerland, among many others.

    This is the second report released by the Global Commission. Its first report, released in June 2011, catalyzed international debate about the urgent need for fundamental reforms of the global drug prohibition regime. It recommended implementing reforms such as alternatives to prison, a greater emphasis on health approaches to drug use, decriminalization, and experiments in drug regulation that avoid the negative effects of full prohibition.

    With widespread media coverage around the world, the report has pushed the topic of drug policy reform back into focus just in time for the International AIDS 2012 Conference, taking place in Washington, DC, later this month. Stressing the need for urgent action, the Global Commission makes a number of recommendations to world leaders and the United Nations, the most fundamental of which being that they acknowledge and address the causal link between the war on drugs and the spread of HIV.

    For more information see:

    Global Commission on Drug Policy: http://www.globalcommissionondrugs.org/
    Canadian HIV/AIDS Legal Network: http://www.aidslaw.ca/EN/index.htm

    Read the Report

  • Director’s Report

    Director’s Report

    The past three months have been a blur of activity as we further establish our presence and connect with organizations and individuals across the country and around the world. There truly is something bigger going on and momentum is building towards considering new and innovative approaches to addressing drug problems.

    Mexico Unido Contra la Delincuencia
    Mexico Unido Contra la Delincuencia

    In February, I was invited to speak at an international conference in Mexico City – Drogas: Un balance a un siglo de su prohicion, organized by the crime prevention group Mexico Unido Contra la Delincuencia. The forum provided a thorough consideration of possible alternatives to the devastating consequences of the Mexican government’s war on drugs. Speakers came from around the world to share stories of innovation, legislative changes and practices that have moved their drug policies towards a public health approach and away from a failed criminal justice model.

    Integrating Supervised Injection Into Health Services and Community: A National Knowledge Exchange

    CAHR 2012 Montréal
    CAHR 2012 Montréal

    In April, CDPC organized a forum on supervised injection services in partnership with the Dr. Peter Centre in Vancouver and Cactus Montreal as an ancillary event at the Canadian Association of HIV Research meeting in Montreal. The event was held in the beautiful Biblioteque et Archive National du Quebec and was a chance for organizations to share their experiences and review the current state of the discussion in their jurisdictions. CDPC will be working with a number of organizations to keep this national discussion moving forward as different localities explore implementing these services.

    North American Drug Strategy Meeting – San Francisco, April 12, 13

    San Fransisco
    San Fransisco

    As part of CDPC’s international work we co-hosted a meeting in partnership with the Drug Policy Alliance in the US and CUPHID from Mexico City to explore the development of a coordinated North American drug policy dialogue. The San Francisco meeting was the initial exploratory session to see how we can work together to bring forward alternatives to North America’s current drug policies. In an effort to strengthen our ties across the continent, CDPC is currently looking for Canadian allies interested in supporting our work in Mexico.

    Visit to the Maritimes

    People & Policies Conference Halifax
    People & Policies Conference Halifax

    As part of our ongoing efforts to build a national coalition I visited Atlantic Canada in May, attending events and meetings in Halifax, Saint John, New Brunswick and Charlottetown. Atlantic Harm Reduction Research Network invited CDPC to be a part of their public session – People and Policies: How do Drug Policies Impact the Health of our Communities? In addition to this, a day-long session with service providers and researchers also considered how best to integrate harm reduction services into shelter and emergency ward settings.

    In Saint John, NB, AIDS Saint John, the Urban and Community Studies Institute at University of New Brunswick and CDPC co-hosted an event – Drugs and the City, which featured a panel discussion on drug policy with Tim Christie, Ethics Director, Saint John Health Region and Bill Reid, Chief of Saint John Police Department.

    In Charlottetown, I met with a number of parents who are concerned about the lack of youth treatment on the Island and are interested in organizing a provincial “addictions movement” to generate discussion, share experiences and engage the provincial government in dialogue on improving services for people with drug problems.

    Thunder Bay Municipal Drug Strategy

    Pot, Pills and Parties Thunder Bay
    Pot, Pills and Parties Thunder Bay

    On May 24th Canadian Students for Sensible Drug Policy and Thunder Bay Drug Strategy put on the event – Pot, Pills and Parties. The event focused on the impact of Bill C-10 on young people and included a presentation from CDPC – Changing the Frame: A New Approach to Drug Policy in Canada.

    As CDPC reaches out across the country we are finding new and innovative ways to strengthen and build our national coalition to improve Canada’s approach to drug problems. We will continue to engage Canadians and work at the international level towards this end.

     


    Photo Credits:
    Mexico – Steve Rolles
    Montréal – Caroline Mousseau
    San Fransisco – CC Flickr evoo73
    Halifax – Wooden Shoe Photography

  • If you can spell it, you can schedule it.

    If you can spell it, you can schedule it.

    That’s the intention of Canada’s federal government.
    Namely, to include methylenedioxypyrovalerone (MDPV), a synthetic substance that causes stimulant-like psychoactive effects, in Schedule I of the Controlled Drugs and Substances Act. At least that’s the proposal formally announced in the Canada Gazette on June 9, 2012. This follows Health Minister Leona Aglukkaq’s announcement that the drug would be banned because of “recent media reports [that] have linked the use of ‘bath salts’ to violence causing harm.” Interested parties have until July 8, 2012 to comment (details below).

    mdvp_thumbAs the Canadian Centre on Substance Abuse so carefully noted, “bath salts are not salts that go in your bath.”

    Rather, it’s the common name given to MDPV, one of the possible ingredients in a substance available for sale, but as of yet, not regulated in Canada, unlike many of its amphetamine-like cousins already prohibited in Schedule III.

    The government’s claim that bath salts are linked to violence stems from highly sensationalistic reporting of a tragic assault case in Miami where a man was shot and killed by police while apparently eating the face of another man. Miami police officials speculated that this attack was caused by the use of bath salts, though toxicology tests won’t be ready for a few weeks. Nor do they care that the man at the centre of this story had a history of violence, according to Kate Heartfield in the Ottawa Citizen.

    The move to ban MDPV comes amid a news cycle in which numerous stories purport to detail the effects of its use, including a segment of CBC’s The Current with Anna Maria Tremonti on May 30th. The Current marshaled interviews from Halifax with a former bath salts user and an addictions treatment doctor to underscore the supposedly uniquely dangerous effects of this drug and give it a homegrown spin. Sound familiar? It should. Similar “drug scare” narratives have been constructed around the popularization of numerous substances, including crystal meth, PCP, crack, speed, LSD, heroin, reefer and of course, opium.

    bathsaltsThe rush to ban MDPV and place it in Schedule I will mean that the harshest drug law penalties can be applied to people who use, traffic or produce this drug. As researchers have noted, the banning of drugs like Mephedrone often drives its use and manufacture further underground, inflates the price and prevents the implementation of potentially helpful forms of regulation. Prohibiting substances has not made people safer, and has not resulted in the elimination of drug use. It can also displace drug use back to traditional illegal drugs, or to newer, potentially more dangerous “legal highs.”

    We don’t want to ignore the voices of people who have negative experiences with MDPV but neither do we want to rush to ban this drug. In this case, it’s a political response that can placate worried voters but it also alleviates politicians of the responsibility to meaningfully address the underlying causes of problematic substance use.  We urge you to express your concerns about this ban.

    Comments on this proposed change can be directed to Mr. Nathan Isotalo, Regulatory Policy Division, Office of Controlled Substances, Address Locator: 3503D, 123 Slater Street, Ottawa, Ontario K1A 0K9, by fax at 613-946-4224 or by email at OCS_regulatorypolicy-BSC_ [email protected].

    For more information see: Curiosity killed M-Cat: A post-legislative study on mephedrone use in Ireland, Marie Claire Van Hout1 & Rebekah Brennan. Drugs: education, prevention and policy, April 2012; 19(2): 156–162.

     

  • Canadian Nurses lead the way in harm reduction

    Canadian Nurses lead the way in harm reduction

    Nurses from across the country will be gathering in Vancouver at the Canadian Nurses Association Biennial Convention this week. As part of the occasion Insite and the Dr Peter Centre are each hosting special sessions on June 17th, providing opportunities for knowledge exchange on harm reduction policies and nursing practice.

    Canadian nurses recognize that substance use, both legal and illegal, is an enduring feature of human existence and that abstinence is not always a realistic goal. As such, nurses focus on reducing adverse consequences and building non-judgmental, supportive relationships for the health and safety of individuals, families and communities.

    Screen-shot-2012-06-14-at-6.53.20-AMThere is a risk that the image of nurse-supervised injection is limited to a nurse hovering over a client while the injection takes place and nothing more occurs. I want to dispel this image.

    The nurses of Insite have articulated their framework of nursing practice. Nursing care is client-centred with the focus on relationship building, maintaining dignity and respect, and creating an environment of cultural safety and empowerment. Primary nursing care at Insite includes safer injection education, needle-syringe exchange, first aid, wound care, overdose management, addiction treatment, reproductive health services and communicable disease prevention. These services are delivered as comprehensive harm reduction and health promotion programming nested in partnerships with the health and social service systems and community agencies.

    In 2011 the Canadian Nurses Association released a discussion paper on Harm reduction and currently illegal drugs: implications for nursing policy, practice, education and research, which was endorsed by the Canadian Association of Nurses in AIDS Care. The values of harm reduction are consistent with the values guiding professional ethical nursing practice articulated in CNA’s Code of Ethics for Registered Nurses for the provision of safe, ethical, competent and compassionate nursing care; for the promotion of health and well-being; for the promotion of and respect for informed decision-making; for the preservation of dignity in which care is provided on the basis of need; and for the promotion of justice.

    Considering this it really shouldn’t come as a surprise that Canadian nurses support harm reduction services. The origins of outreach nursing have been attributed to the Grey Nuns, founded by Marguerite d’Youville in Montreal, who by the mid 1700’s, were known for their care to the destitute. Inequity of access to health care and the basic determinants of health has led to “street nursing” practices in many urban centres.

    Lightfoot-etal_09_Gaining-Insite Harm_Reduction_2011_e Hardill

    BCCDC-STI Street Outreach Nurse Program
    BCCDC-STI Street Outreach Nurse Program

    In Vancouver, after World War II nurses led a major effort to reach marginalized people who would not attend hospitals for the treatment of sexually transmitted diseases. In 1988 the BC Centre for Disease Control established the AIDS Prevention Street Nurse Program with a focus on needle and syringe exchange. With the epidemics of overdose deaths and the dramatic outbreak of HIV that Vancouver experienced in the 1990’s, the street nurses were some of the first to advocate for bringing injecting from the alleys into the safety of a supervised injection health service.

    Just over one year ago, professional associations – Canadian Nurses Association, Registered Nurses Association of Ontario and Association of Registered Nurses of British Columbia and BC Nurses Union each acted as intervenors in support of Insite at the Supreme Court of Canada. Nurses across Canada cheered when the Supreme Court ruled in favour of Insite remaining open.

    Look for nurses to be leaders in advocating for the expansion of supervised injection services locally, nationally and globally!

     

     

  • Mark Haden: A Drug Educator’s Apology

    Mark Haden: A Drug Educator’s Apology

    Mark Haden is a drug educator. He has spent the last twenty-five years providing public education on drugs and working with addiction counselling services in Canada. Today he works as a supervisor at the Pacific Spirit Community Health Centre in Vancouver.

    Haden knows that the Canadian Federal government spends approximately six million dollars a year educating parents, teachers, young people, law enforcement and communities about the risks and laws surrounding substance use. He also knows that drug education plays a key role in defining our relationships to mind altering substances.

    “We have overemphasized the harms of drugs, we have neglected to mention the benefits of certain drugs and we have omitted mentioning the harms that drug prohibition causes….”

    Reflecting on the complexity of the relationships we have to drugs, Haden feels that we do a disservice to young people by perpetuating certain myths and maintaining a system that fails to achieve healthy results. During a brief interview in his office, Haden suggested a number of regulatory tools that could be useful in redefining our relationship to drugs and drug education. He advocates for a public health approach that is rooted in human rights and harm reduction and proposes an alternative to prohibition and criminalization.

    Haden is adamant that it is time to explore alternate regulatory frameworks that will actually make certain drugs harder to attain for young people, not easier. He admits that different drugs have different properties and risks and suggests that we consider each one separately, with different approaches taken to reducing the harms of each drug.

    Haden believes that if we can open up discussion about drug use and create public health policies, we can also begin to develop healthy social norms that can minimize their associated harms. “We don’t drink alcohol with breakfast,” he says. If we stop the violence of prohibition and start telling the truth about drugs, then we can begin to develop healthy social habits around drug use.

    Mark’s website has an extensive list of regulatory tools as well as many more resources for understanding and shifting our relationship to drugs towards a public health approach.